FFG
AZN icon

Frisch Financial Group’s AstraZeneca AZN Stock Holding History

Frisch Financial Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,104
Closed -$210K – 106
2019
Q4 		$210K Buy
+2,104
New +$198K 0.1% 110

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Frisch Financial Group's AZN Position: Q1 2020 in Review

Frisch Financial Group sold out of AstraZeneca (AZN) in Q1 2020, closing a stake of 2,104 shares — an estimated $210K sold.

Frisch Financial Group first reported a position in AZN in Q4 2019 and held it in 1 quarter. The position peaked at $210K in Q4 2019. 603 funds tracked by Wall St. Rank hold AZN as of Q1 2020.

  • Frisch Financial Group reported no remaining AstraZeneca position as of Q1 2020 after selling out during the quarter.
  • Frisch Financial Group sold 2,104 AstraZeneca shares in Q1 2020, an estimated $210K.
  • Frisch Financial Group first reported a position in AstraZeneca in Q4 2019 and held it in 1 quarter.
  • Frisch Financial Group's AstraZeneca position peaked at $210K in Q4 2019.
  • 603 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2020.

Based on Frisch Financial Group's 13F filing for Q1 2020, filed 8 May 2020.